2877 — China Shineway Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$6.15bn
- -HK$2.32bn
- CNY3.14bn
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln
Brief: China Shineway Pharmaceutical Posts Turnover For Q1 Of RMB1.12 Bln
Brief: China Shineway Pharmaceutical Sees Profit Attributable To Increase By 30% To 36% For Year
Chinese developer CIFI leads Hong Kong Stock Connect program's newcomers higher
Brief: China Shineway Pharmaceutical Says Liu Tiejun Tendered Resignation As Executive Director
Brief: China Shineway Pharmaceutical Posts Turnover For Three Months Of RMB1.19 Bln
China Shineway Pharmaceutical at 22-month peak on strong Q1 turnover
Brief: China Shineway Pharmaceutical Says Profit For Year RMB722.8 Mln
Brief: China Shineway Pharmaceutical Says 9-Month Turnover Up 21.9%
Brief: China Shineway Pharmaceutical Says Liu Tiejun Appointed As Executive Director
Brief: China Shineway Pharmaceutical Says HY Profit And Total Comprehensive Income Rmb331.1 Mln
Brief: China Shineway Pharmaceutical Sees Profit Attributable For Year To Increase By Approximately 85% To 95%
Brief: China Shineway Pharmaceutical Says 9-Mth Turnover RMB2,337 Mln, Up 24.3%
Brief: China Shineway Pharmaceutical Anticipates Dividends Of RMB60 Cents/Share To Be Declared In CY2021
Brief: Shineway (2877.Hk)’S First 4 Months Sales From The Internet This Year Up By 209.2%
Brief: China Shineway Pharmaceutical Group Ltd Sees Profit Attributable To Decrease By About 40% To 50% For Year